Table 2.
Mean NHS costs and MCD for PDD-TURBT and WL-TURBT by cost category over 3 yr (2018–2019 values)
| Item | MCPP, £ (standard deviation) |
MCD per participant, £ (95% CI) | |
|---|---|---|---|
| PDD-TURBT | WL-TURBT | ||
| Total NHS costs | 12 927 (10 994) | 11 934 (8235) | 993 (−724 to 2709) |
| Intervention | |||
| First TURBT | |||
| Length of operation | 92 (45) | 84 (75) | 8 (−3 to 19) |
| Drugs in theatre: Hexvix | 323 (89) | 1 (22) | 321 (310 to 333) |
| Length of stay | 2914 (4189) | 2546 (2959) | 369 (−272 to 1009) |
| Postoperative instillation of MMC | 521 (446) | 554 (440) | −33 (−111 to 45) |
| Subtotal | 3851 (4153) | 3185 (2964) | 666 (28 to 1303) |
| Second TURBT | |||
| Length of operation | 89 (53) | 77 (51) | 11 (−5 to 28) |
| ubtotal | 89 (53) | 77 (51) | 11 (−5 to 28) |
| Total intervention costs | 3879 (4157) | 3210 (2967) | 669 (31 to 1308) |
| Follow-up management (1 yr) | |||
| Secondary care | |||
| Inpatient stay | 2363 (4970) | 2469 (4591) | −106 (−953 to 740) |
| Cystectomy | 854 (2,863) | 920 (2962) | −67 (−582 to 449) |
| Resection surgery | |||
| Length of operation | 11 (28) | 15 (32) | −4 (−10 to 1) |
| Length of stay | 168 (367) | 222 (402) | −54 (−122 to 14) |
| Cystoscopy | 1559 (1077) | 1437 (1011) | 122 (−63 to 307) |
| Hospital doctor consultation | |||
| Telephone | 1 (6) | 1 (7) | 0 (−1 to 1) |
| Out of hours | 4 (25) | 9 (46) | −5 (−11 to 2) |
| Outpatient consultations (face to face) | 787 (786) | 805 (829) | −18 (−161 to 125) |
| A&E consultations (face to face) | 57 (306) | 41 (125) | 16 (−25 to 57) |
| Subtotal | 5804 (6649) | 5920 (,323) | −116 (−1264 to 1032) |
| Primary care | |||
| Face to face | |||
| GP consultations | 34 (60) | 33 (58) | 1 (−10 to 11) |
| GP home visits | 14 (61) | 14 (114) | 0 (−16 to 16) |
| Nurse consultations | 24 (61) | 27 (70) | −3 (−15 to 8) |
| Nurse home visits | 22 (89) | 19 (76) | 3 (−12 to 18) |
| Telephone consultations | |||
| GP-led | 4 (14) | 5 (18) | −1 (−4 to 2) |
| Nurse-led | 5 (12) | 5 (15) | 0 (−2 to 2) |
| Other | 1 (5) | 2 (10) | −1 (−2 to 1) |
| Out-of-hours consultations | |||
| GP | 4 (31) | 3 (22) | 1 (−4 to 6) |
| Nurse | 6 (41) | 4 (31) | 2 (−4 to 9) |
| Other | 2 (17) | 1 (11) | 1 (−2 to 3) |
| Subtotal | 116 (195) | 114 (228) | 2 (−36 to 40) |
| Follow-up management (2–3 yr) | |||
| Secondary care | |||
| Inpatient stay | 955 (6438) | 552 (2995) | 403 (−483 to 1288) |
| Cystectomy | 245 (1545) | 280 (1651) | −36 (−319 to 248) |
| Resection surgery | |||
| Length of operation | 10 (26) | 4 (18) | 5 (1 to 9) |
| Length of stay | 139 (334) | 61 (225) | 78 (28 to 128) |
| Cystoscopy | 1279 (1287) | 1267 (1323) | 13 (−218 to 244) |
| Hospital doctor consultation | |||
| Telephone | 15 (44) | 12 (36) | 3 (−4 to 10) |
| Out of hours | 4 (45) | 14 (194) | −11 (−36 to 15) |
| Outpatient consultations (face to face) | 9 (38) | 15 (50) | −6 (−14 to 2) |
| A&E consultations (face to face) | 4 (21) | 3 (23) | 1 (−3 to 5) |
| Subtotal | 3089 (7492) | 2639 (4557) | 451 (−644 to 1546) |
| Primary care | |||
| Face to face | |||
| GP consultations | 15 (44) | 12 (36) | 3 (−4 to 10) |
| GP home visits | 4 (45) | 14 (194) | −11 (−36 to 15) |
| Nurse consultations | 9 (38) | 15 (50) | −6 (−14 to 2) |
| Nurse home visits | 4 (21) | 3 (23) | 1 (−3 to 5) |
| Telephone consultations | |||
| GP led | 2 (10) | 2 (23) | −1 (−4 to 3) |
| Nurse led | 2 (7) | 2 (8) | 0 (−2 to 1) |
| Other | 0 (3) | 0 (1) | 0 (0 to 1) |
| Out-of-hours consultations | |||
| GP | 1 (9) | 0 (4) | 0 (−1 to 2) |
| Nurse | 1 (9) | 1 (18) | 0 (−3 to 2) |
| Other | 1 (14) | 1 (12) | 0 (−3 to 2) |
| Subtotal | 38 (101) | 52 (257) | −14 (−48 to 21) |
| Total follow-up costs | 9048 (10 071) | 8724 (7677) | 323 (−1259 to 1906) |
A&E = accident and emergency department; GP = general practitioner; MMC = mitomycin C; NHS = National Health Service; TURBT = transurethral resection of bladder tumour; PDD-TURBT = photodynamic diagnosis–guided TURBT; WL-TURBT = white light–guided TURBT; MCD = mean cost difference; MCPP = mean cost per participant; SD = standard deviation; CI = confidence interval.